We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK MOVING R&D ABROAD; SEES SAVINGS IN ELECTRONIC DATA CAPTURE
GSK MOVING R&D ABROAD; SEES SAVINGS IN ELECTRONIC DATA CAPTURE
November 4, 2004
GlaxoSmithKline (GSK) is on track to move as much as 30 percent of its human clinical drug trials to low-cost countries, according to the drugmaker’s top executive.